EXHIBIT 10.32 AMENDMENT TO SUBLICENSE AND DEVELOPMENT AGREEMENT This AMENDMENT TO SUBLICENSE AND DEVELOPMENT AGREEMENT (the "Amendment") is made this 28th day of September, 2001, by and between SHEFFIELD PHARMACEUTICALS, INC., a Delaware corporation...Sublicense and Development Agreement • November 14th, 2001 • Sheffield Pharmaceuticals Inc • Pharmaceutical preparations
AMENDMENTSublicense and Development Agreement • March 31st, 2008 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New York
AMENDMENT dated October 29, 2007 to the Sublicense and Development Agreement dated June 30, 1998 (the “Sublicense Agreement”) by and between DOV Pharmaceutical, Inc. 150 Pierce St., Somerset, NJ 08873 (“DOV”) and Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130 (“Neurocrine”).
Exhibit 10.3 SUB-LICENSE AND DEVELOPMENT AGREEMENT THIS AGREEMENT is effective this 30th day of June 1998, by and between DOV Pharmaceutical, Inc., a New Jersey corporation, with offices at 1 Parker Plaza, Suite 1500 Fort Lee, New Jersey 07024 ("DOV")...Sublicense and Development Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
